文献速递糖尿病

1型糖尿病进展过程中C肽从代偿性升高转为下降及其与风险的关系

The Transition From a Compensatory Increase to a Decrease in C-peptide During the Progression to Type 1 Diabetes and Its Relation to Risk.
PubMed 文献 · Diabetes Care · 2022-01-01

在DPT-1(n=72)和TNPTP(n=82)两个队列中纵向分析OGTT葡萄糖与C肽反应曲线,发现AUC C肽从基线升至诊断前1.5年、随后降至诊断前0.5年,该转折点中位Index60值可作为识别1型糖尿病高危个体的病理生理阈值。

要点

  • AUC C肽在诊断前1.5年由升转降,该转折在两个独立队列中均得到验证。
  • 转折主要归因于晚期(60-120分钟)AUC C肽反应的变化。
  • 诊断前1.5年中位Index60值可作为识别1型糖尿病高危个体的阈值。

核心结论

  • AUC C肽在诊断前约1.5年由升高转为下降,该转折在两个独立队列中得到验证。
  • 该时间点的中位Index60值可作为基于病理生理的阈值,用于识别1型糖尿病高危个体。

研究设计与样本

  • 纵向研究,分析DPT-1(n=72)和TNPTP(n=82)参与者在基线和诊断前多个随访时间点的OGTT数据。
  • 计算葡萄糖和C肽反应曲线(GCRC)、葡萄糖曲线下面积(AUC)、C肽AUC及整合OGTT葡萄糖与C肽值的Index60。

主要发现

  • 从基线至诊断前0.5年,葡萄糖AUC持续升高。
  • C肽AUC从基线升至诊断前1.5年(DPT-1,P=0.004;TNPTP,P=0.012),随后从诊断前1.5年降至0.5年(DPT-1,P=0.017;TNPTP,P=0.093)。
  • C肽AUC的变化主要归因于晚期(60-120分钟)C肽AUC反应的变化。
  • DPT-1和TNPTP中1型糖尿病进展者在诊断前1.5年的中位Index60值分别为1.44和1.05。
  • 在基线全队列中,高于上述阈值的个体5年1型糖尿病风险为0.75-0.88。

关键数值与推荐

  • DPT-1进展者诊断前1.5年中位Index60值为1.44。
  • TNPTP进展者诊断前1.5年中位Index60值为1.05。
  • 高于阈值者基线时5年1型糖尿病风险为0.75-0.88。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To define the relationship between glucose and C-peptide during the progression to type 1 diabetes (T1D). RESEARCH DESIGN AND METHODS: We longitudinally studied glucose and C-peptide response curves (GCRCs), area under curve (AUC) for glucose, and AUC C-peptide from oral glucose tolerance tests (OGTTs), and Index60 (which integrates OGTT glucose and C-peptide values) in Diabetes Prevention Trial-Type 1 (DPT-1) (n = 72) and TrialNet Pathway to Prevention Study (TNPTP) (n = 82) participants who had OGTTs at baseline and follow-up time points before diagnosis. RESULTS: Similar evolutions of GCRC configurations were evident between DPT-1 and TNPTP from baseline to 0.5 years prediagnosis. Whereas AUC glucose increased throughout from baseline to 0.5 years prediagnosis, AUC C-peptide increased from baseline until 1.5 years prediagnosis (DPT-1, P = 0.004; TNPTP, P = 0.012) and then decreased from 1.5 to 0.5 years prediagnosis (DPT-1, P = 0.017; TNPTP, P = 0.093). This change was mostly attributable to change in the late AUC C-peptide response (i.e., 60- to 120-min AUC C-peptide). Median Index60 values of DPT-1 (1.44) and TNPTP (1.05) progressors to T1D 1.5 years prediagnosis (time of transition from increasing to decreasing AUC C-peptide) were used as thresholds to identify individuals at high risk for T1D in the full cohort at baseline (5-year risk of 0.75-0.88 for those above thresholds). CONCLUSIONS: A transition from an increase to a decrease in AUC C-peptide ∼1.5 years prediagnosis was validated in two independent cohorts. The median Index60 value at that time point can be used as a pathophysiologic-based threshold for identifying individuals at high risk for T1D.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Ismail HM, Cuthbertson D, Gitelman SE, et al. The Transition From a Compensatory Increase to a Decrease in C-peptide During the Progression to Type 1 Diabetes and Its Relation to Risk. Diabetes Care. 2022. PMID: 35998266. doi:10.2337/dc22-0167

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。